Across rheumatic diseases

The utility of machine learning-based decision support system in referral of suspected rheumatic disease

Clin Exp RheumatolPublished Diagnostic accuracy study

Authors' conclusion

This ML-based triage tool demonstrates strong potential for accurately identifying appropriate referrals, reducing unnecessary consultations, and enhancing resource utilisation in rheumatology clinics.

Study context

Population
Participants attending a rheumatology outpatient clinic for the first time with suspected rheumatic diseases (RD)574 diagnosed with RD
Participants
843 participants
Outcome
Accuracy (sensitivity, specificity, AUC) of the ML model in identifying correct vs unnecessary referral, against rheumatologic disease status at follow-up
Follow-up
6 months
Methodological detailsmachine learning model development and evaluation, fivefold cross-validation, 6-month follow-up
  • Machine learning model development and evaluation
  • Fivefold cross-validation
  • 6-month follow-up

Performance

As reported in the abstract

Identification of appropriate referral, mean across five folds
Test or modelAUC (mean)Sensitivity (mean)Specificity (mean)
Machine learning (ML) model77.9% (95% CI: 74.9%-80.9%)87.1% (95% CI: 84.4%-89.8%)67.8% (95% CI: 62.2%-73.3%)

Machine learning (ML) model

AUC (mean)77.9% (95% CI: 74.9%-80.9%)
Sensitivity (mean)87.1% (95% CI: 84.4%-89.8%)
Specificity (mean)67.8% (95% CI: 62.2%-73.3%)
Participants referred unnecessarily
31.9%

Further findings

Best-performing fold

AUC
81.34% (95% CI 78.58%-84.22%)
Sensitivity (78.58%- 4.90%)
81.74%
Specificity (76.26%-85.64%)
80.95%

Best fold after addition of four questions (n=245)

AUC
90.77% (95% CI 87.20-94.34)
Sensitivity
89.74% (95% CI 85.14-94.34)
Specificity
92.05% (95% CI 86.05-98.05)
Performance metrics significantly improved

Original publication

The utility of machine learning-based decision support system in referral of suspected rheumatic disease. Clin Exp Rheumatol. Published 3 July 2025. doi:10.55563/clinexprheumatol/31phae

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.